20 May 2013
News | 09 January 2013
The overall ratings of four Biotechnology stocks are down on Portfolio Grader this week. Each of these rates a ?D? (?sell?) or ?F? overall (?strong sell?). BioTime's (AMEX:BTX) rating falls this week to an F (?strong sell?), down from last week's D ...
Click on the link to read the full article at Investorplace.com
(This link will open in a new window)